Clinical trial
Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina
NCT00225342 · University of Glasgow, Other · Withdrawn
Key facts
| NCT number | NCT00225342 |
|---|---|
| Title | Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina |
| Official title | Effects of Rosiglitazone and Sulphonylureas on Ischaemic Burden, Blood Pressure and Novel Risk Markers Inclusive of Vascular Function in Patients With Chronic Stable Angina and Type 2 Diabetes Mellitus: A Randomised, Double-Blinded Study. |
| Lead sponsor | University of Glasgow, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Angina Pectoris, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Gliclazide (Comparison drug) |
| Enrollment | 60 |
| First posted | Sep 23, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: